BICO Group AB buy Max1111
Start price
17.07.23
/
100%
€3.83
Target price
17.07.25
€20.00
Performance (%)
-8.75%
Price
19:53
€3.49
Summary
This prediction is currently active. With a performance of -8.75%, the BUY prediction for BICO Group AB by Max1111 is down slightly. This prediction currently runs until 17.07.25. The prediction end date can be changed by Max1111 at any time. Max1111 has 100% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BICO Group AB | -9.348% | -9.348% |
| iShares Core DAX® | 3.178% | 0.980% |
| iShares Nasdaq 100 | 2.972% | 0.925% |
| iShares Nikkei 225® | 0.545% | -4.556% |
| iShares S&P 500 | 2.367% | 0.833% |
According to Max1111 what are the pros and cons of BICO Group AB for the foreseeable future?
Pros
EBIT growth > 30% per year expected
Capable Management
Strong uniques
High Investments for future growth
Revenue growth > 30% per year expected
Leading role in innovation
Growths much faster than the competition
Market Leader or Top 3
Known brand
Very Future proof/growth oriented business model
Cons
Increased challenges to pay loans and raise capital
Risky balance sheet
ROE lower than 10% per year
Comments by Max1111 for this prediction
In the thread Cellink Ab diskutieren
Kursziel gesetzt auf 20,0
Führend im Bioprinting; 10 % Beteiligung von Sartorius<; momentan noch nicht Profitabel.
DYOR
https://bico.com/
DYOR
https://bico.com/